Co-organized by Temasek Foundation, Medicines for Malaria Venture, Medicines Patent Pool, Drugs for Neglected Diseases initiative, Global Antibiotic Research and Development Partnership, and the International AIDS Society, this strategy launch and panel discussion will bring together country leaders and global health partners. Together, we will explore how to strengthen the ecosystem that supports the development, approval, and uptake of paediatric medicines—with a focus on leadership, cross-sector collaboration, and impact-driven action.
Venue: Jardin de Penthes, Chemin de l’Impératrice 18, 1292 Pregny-Chambésy, Geneva, Switzerland
Agenda
Opening
| Welcome remarks Jeremy Farrar, Chief Scientist, WHO |
Keynote address
| Partnering for affordable and accessible treatments Nor Fariza binti Ngah, Deputy Director-General of Health of Malaysia (Research & Technical Support) |
Launch of GAP-f strategy and key collaborations
| Accelerating the development & rollout of optimal medicines in formulations adapted to children Martina Penazzato, GAP-f Lead, WHO |
| Launch of the WHO collaboration with Temasek Foundation Ng Boon Heong, CEO, Temasek) |
Strengthening the global ecosystem for paediatric medicines: Mobilizing stakeholder & driving impact
Chair: Janet Ginnard, Unitaid
| Advancing clinical research & strengthening the clinical trials ecosystem Lydia Boudarene, EDCTP |
| Developing the right formulations more efficiently Caroline Boulton, Novartis |
| Ensuring accelerated and sustained access Speaker from Ecuador delegation to be confirmed |
| Leveraging the power of communities Pat Garcia-Gonzalez, The Max Foundation |
Closing
Charles Gore, Vice-Chair, GAP-f Strategy Group / Executive Director, MPP
